LBF20207PG53
| LipidBank Top (トップ) |
Fatty acid (脂肪酸) |
Glycerolipid (グリセロ脂質) |
Sphingolipid (スフィンゴ脂質) |
Journals (雑誌一覧) |
How to edit (ページの書き方) |
| IDs and Links | |
|---|---|
| LipidBank | XPR1732 |
| LipidMaps | LMFA03010050 |
| CAS | |
| KEGG | {{{KEGG}}} |
| KNApSAcK | {{{KNApSAcK}}} |
| mol | LBF20207PG53 |
| 15S-15-methyl Prostaglandin D2 | |
|---|---|
| |
| Structural Information | |
| (9α,15S) -Dihydroxy-11-oxo-15-methylprosta- (5-cis,13-trans) -dien-1-oic acid | |
| |
| Formula | C21H34O5 |
| Exact Mass | 366.240624198 |
| Average Mass | 366.49166 |
| SMILES | C(=C[C@H]([C@H]1CC=CCCCC(O)=O)C(C[C@@H]1O)=O)[C@](C)(O)CCCCC |
| Physicochemical Information | |
| 15(S)-15-methyl Prostaglandin D2 is reported to inhibit ADP-induce human platelet aggregation (IC50 value of 320 ng/ml) and increase systemic blood pressure in rat. Bundy_GL et al.15(S)-15-methyl Prostaglandin D2 shows strong anti-fertility effect in hamster (100% at 50 mu g/hamster). Bundy_GL et al. | |
| Spectral Information | |
| Mass Spectra | |
| UV Spectra | |
| IR Spectra | |
| NMR Spectra | |
| Other Spectra | |
| Chromatograms | |
| Reported Metabolites, References | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
